PriceTargets.com logo

The Carlyle Group - CG Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $53.33
  • Forecasted Upside: 4.11%
  • Number of Analysts: 15
  • Breakdown:
  • 0 Sell Ratings
  • 9 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$51.23 As of 11/20/2024 01:00 AM ET
▲ +0.09 (0.18%)

This chart shows the closing price for CG by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New The Carlyle Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CG and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CG

Analyst Price Target is $53.33
▲ +4.11% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for The Carlyle Group in the last 3 months. The average price target is $53.33, with a high forecast of $85.00 and a low forecast of $44.00. The average price target represents a 4.11% upside from the last price of $51.23.

This chart shows the closing price for CG for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 15 investment analysts is to hold stock in The Carlyle Group. This rating has held steady since April 2024, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 11 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
5/30/2023
  • 0 strong buy ratings
  • 10 buy ratings
  • 3 hold ratings
  • 1 sell ratings
Ratings as of
8/28/2023
  • 0 strong buy ratings
  • 8 buy ratings
  • 4 hold ratings
  • 1 sell ratings
Ratings as of
11/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
2/24/2024
  • 0 strong buy ratings
  • 7 buy ratings
  • 8 hold ratings
  • 0 sell ratings
Ratings as of
5/24/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
8/22/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/11/2024OppenheimerBoost TargetOutperform ➝ Outperform$78.00 ➝ $85.00
11/8/2024BarclaysBoost TargetOverweight ➝ Overweight$50.00 ➝ $57.00
11/8/2024TD CowenBoost TargetHold ➝ Hold$43.00 ➝ $49.00
11/8/2024Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$51.00 ➝ $55.00
10/23/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$44.00 ➝ $50.00
10/22/2024UBS GroupBoost TargetNeutral ➝ Neutral$43.00 ➝ $54.00
10/16/2024OppenheimerBoost TargetOutperform ➝ Outperform$64.00 ➝ $78.00
10/14/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$45.00 ➝ $47.00
10/10/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$46.00 ➝ $50.00
10/9/2024JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$60.00 ➝ $60.00
10/9/2024Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$42.00 ➝ $48.00
10/7/2024BarclaysBoost TargetOverweight ➝ Overweight$46.00 ➝ $50.00
9/12/2024Wells Fargo & CompanyInitiated CoverageEqual Weight$42.00
8/27/2024Redburn AtlanticInitiated CoverageBuy$55.00
8/15/2024Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$55.00 ➝ $53.00
8/6/2024TD CowenBoost TargetHold ➝ Hold$41.00 ➝ $42.00
8/6/2024BarclaysLower TargetOverweight ➝ Overweight$51.00 ➝ $46.00
8/6/2024Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$52.00 ➝ $55.00
8/6/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$48.00 ➝ $46.00
8/6/2024OppenheimerLower TargetOutperform ➝ Outperform$69.00 ➝ $64.00
8/6/2024JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$46.00 ➝ $44.00
7/22/2024BarclaysBoost TargetOverweight ➝ Overweight$47.00 ➝ $51.00
7/10/2024UBS GroupLower TargetNeutral ➝ Neutral$45.00 ➝ $44.00
7/8/2024TD CowenLower TargetHold ➝ Hold$45.00 ➝ $41.00
5/9/2024Jefferies Financial GroupLower TargetHold ➝ Hold$49.00 ➝ $44.00
5/2/2024BarclaysLower TargetOverweight ➝ Overweight$56.00 ➝ $47.00
5/2/2024TD CowenLower TargetHold ➝ Hold$49.00 ➝ $45.00
5/2/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$54.00 ➝ $48.00
5/2/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ Market Perform$50.00 ➝ $48.00
5/2/2024OppenheimerLower TargetOutperform ➝ Outperform$74.00 ➝ $68.00
4/12/2024UBS GroupBoost TargetNeutral ➝ Neutral$46.00 ➝ $50.00
4/8/2024BarclaysBoost TargetOverweight ➝ Overweight$55.00 ➝ $56.00
2/23/2024BarclaysBoost TargetOverweight ➝ Overweight$53.00 ➝ $55.00
2/8/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$39.00 ➝ $45.00
2/8/2024BarclaysBoost TargetOverweight ➝ Overweight$46.00 ➝ $53.00
2/8/2024JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$52.00 ➝ $58.00
2/8/2024CitigroupBoost TargetNeutral ➝ Neutral$41.00 ➝ $45.00
1/24/2024Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$34.00 ➝ $40.00
1/19/2024CitigroupDowngradeBuy ➝ Neutral$40.00 ➝ $41.00
1/11/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$38.00 ➝ $39.00
1/4/2024TD CowenInitiated CoverageMarket Perform$42.00
11/29/2023Evercore ISIDowngradeOutperform ➝ In-Line$32.00
11/8/2023JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$35.00 ➝ $38.00
10/18/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$35.00 ➝ $34.00
10/11/2023Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$43.00 ➝ $44.00
10/10/2023Jefferies Financial GroupLower Target$35.00 ➝ $31.00
10/10/2023BarclaysBoost TargetOverweight ➝ Overweight$37.00 ➝ $39.00
10/9/2023OppenheimerLower TargetOutperform ➝ Outperform$58.00 ➝ $53.00
10/6/2023Bank of AmericaLower Target$31.00 ➝ $30.00
10/4/2023Wolfe ResearchInitiated CoverageMarket Perform
8/17/2023JMP SecuritiesReiterated RatingMarket Outperform ➝ Market Outperform$52.00
8/3/2023Piper SandlerLower TargetOverweight ➝ Overweight$42.00 ➝ $40.00
8/3/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$34.00 ➝ $35.00
8/3/2023OppenheimerLower TargetOutperform ➝ Outperform$60.00 ➝ $58.00
8/3/2023BarclaysLower TargetOverweight ➝ Overweight$38.00 ➝ $37.00
7/19/2023UBS GroupBoost TargetNeutral$28.00 ➝ $35.00
7/18/2023Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $34.00
7/13/2023BarclaysBoost Target$32.00 ➝ $38.00
5/18/2023CitigroupInitiated CoverageBuy$40.00
5/18/2023Piper SandlerLower Target$46.00 ➝ $42.00
5/8/2023UBS GroupLower Target$33.00 ➝ $28.00
5/5/2023500.comReiterated RatingMaintains
5/5/2023Deutsche Bank AktiengesellschaftLower Target$41.00 ➝ $39.00
5/5/2023BMO Capital MarketsLower Target$44.00 ➝ $37.00
5/5/2023BarclaysLower Target$41.00 ➝ $32.00
5/5/2023JMP SecuritiesLower Target$54.00 ➝ $52.00
4/19/2023Morgan StanleyLower TargetEqual Weight$37.00 ➝ $35.00
4/13/2023OppenheimerBoost TargetOutperform$64.00 ➝ $65.00
4/5/2023Bank of AmericaLower TargetUnderperform$34.00 ➝ $33.00
4/4/2023Piper SandlerLower TargetOverweight$48.00 ➝ $46.00
3/13/2023JMP SecuritiesReiterated RatingMarket Outperform$54.00
3/2/2023BarclaysInitiated CoverageOverweight$41.00
2/9/2023The Goldman Sachs GroupBoost TargetBuy$37.00 ➝ $42.00
2/8/2023Deutsche Bank AktiengesellschaftBoost Target$41.00 ➝ $43.00
2/8/2023Piper SandlerLower TargetOverweight$58.00 ➝ $48.00
1/25/2023OppenheimerBoost TargetOutperform$60.00 ➝ $61.00
1/24/2023Morgan StanleyBoost TargetEqual Weight$34.00 ➝ $37.00
1/2/2023Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$36.00
12/14/2022OppenheimerBoost Target$60.00
11/23/2022Credit Suisse GroupSet Target$36.00
11/15/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$33.00 ➝ $35.00
11/15/2022UBS GroupLower TargetNeutral$40.00 ➝ $31.00
11/14/2022Morgan StanleyLower TargetEqual Weight$35.00 ➝ $34.00
11/10/2022BMO Capital MarketsLower TargetOutperform$57.00 ➝ $50.00
11/9/2022The Goldman Sachs GroupLower TargetBuy$42.00 ➝ $37.00
11/9/2022Credit Suisse GroupLower TargetOutperform$38.50 ➝ $36.50
11/9/2022JMP SecuritiesLower TargetMarket Outperform$58.00 ➝ $54.00
11/9/2022Deutsche Bank AktiengesellschaftLower Target$36.00 ➝ $33.00
10/19/2022Morgan StanleyLower TargetEqual Weight$41.00 ➝ $35.00
10/18/2022JPMorgan Chase & Co.Lower TargetOverweight$53.00 ➝ $45.00
10/18/2022Credit Suisse GroupInitiated CoverageOutperform$38.50
10/12/2022Deutsche Bank AktiengesellschaftLower TargetBuy$43.00 ➝ $36.00
10/11/2022JMP SecuritiesLower TargetMarket Outperform$60.00 ➝ $58.00
10/11/2022Piper SandlerLower Target$68.00 ➝ $62.00
10/6/2022Bank of AmericaReiterated RatingUnderperform ➝ Underperform$34.00
10/3/2022The Goldman Sachs GroupLower TargetBuy$47.00 ➝ $42.00
9/6/2022Bank of AmericaDowngradeBuy ➝ Underperform$58.00 ➝ $33.00
8/12/2022Deutsche Bank AktiengesellschaftLower Target$56.00 ➝ $43.00
8/11/2022Royal Bank of CanadaLower TargetOutperform$15.00 ➝ $11.00
8/10/2022Evercore ISIDowngradeBuy ➝ Hold$55.00 ➝ $38.00
8/9/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$55.00 ➝ $38.00
8/2/2022Morgan StanleyBoost TargetEqual Weight$39.00 ➝ $41.00
8/1/2022UBS GroupBoost TargetNeutral$34.00 ➝ $40.00
7/29/2022Evercore ISIUpgradeIn-Line ➝ Outperform$38.00 ➝ $45.00
7/19/2022Morgan StanleyLower TargetEqual Weight$50.00 ➝ $30.00
7/13/2022Deutsche Bank AktiengesellschaftLower TargetBuy$64.00 ➝ $56.00
6/29/2022The Goldman Sachs GroupLower TargetBuy$58.00 ➝ $48.00
6/8/2022JMP SecuritiesInitiated CoverageOutperform$60.00
5/19/2022Deutsche Bank AktiengesellschaftLower Target$68.00 ➝ $64.00
4/29/2022BMO Capital MarketsLower Target$69.00 ➝ $60.00
4/20/2022Morgan StanleyLower TargetEqual Weight$59.00 ➝ $54.00
4/13/2022OppenheimerBoost Target$71.00 ➝ $80.00
4/7/2022Deutsche Bank AktiengesellschaftBoost TargetBuy$68.00 ➝ $70.00
4/1/2022BMO Capital MarketsBoost TargetOutperform$65.00 ➝ $69.00
3/29/2022The Goldman Sachs GroupLower TargetBuy ➝ Buy$66.00 ➝ $56.00
1/18/2022Raymond JamesBoost TargetMarket Perform$12.50 ➝ $13.00
12/16/2021Bank of AmericaInitiated CoverageBuy$79.00
11/2/2021CitigroupBoost TargetBuy$66.00 ➝ $73.00
10/29/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$63.00 ➝ $70.00
10/29/2021OppenheimerBoost TargetOutperform$69.00 ➝ $77.00
10/15/2021Morgan StanleyBoost TargetEqual Weight$53.00 ➝ $57.00
9/13/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$59.00 ➝ $65.00
8/11/2021CIBCUpgradeNeutral
8/11/2021Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$53.00 ➝ $58.00
7/20/2021Morgan StanleyBoost TargetEqual Weight$44.00 ➝ $49.00
7/12/2021Deutsche Bank AktiengesellschaftBoost TargetHold$45.00 ➝ $51.00
7/12/2021CitigroupBoost TargetTop Pick ➝ Buy$51.50 ➝ $54.50
6/16/2021CitigroupBoost TargetBuy$49.50 ➝ $51.50
5/19/2021CIBCLower TargetUnderperformer$10.00 ➝ $9.00
5/12/2021TD SecuritiesLower TargetHold$15.50 ➝ $10.00
5/4/2021CitigroupBoost Target$43.50 ➝ $49.50
5/4/2021Morgan StanleyBoost TargetEqual Weight$41.00 ➝ $44.00
4/16/2021Morgan StanleyBoost TargetEqual Weight$40.00 ➝ $41.00
2/25/2021Morgan StanleyBoost TargetEqual Weight$38.00 ➝ $40.00
2/24/2021BarclaysBoost Target$36.00 ➝ $39.00
2/24/2021Deutsche Bank AktiengesellschaftBoost TargetHold$37.00 ➝ $39.00
2/19/2021Credit Suisse GroupUpgradeNeutral ➝ Outperform$40.00 ➝ $42.00
2/8/2021CitigroupBoost Target$38.00 ➝ $43.50
2/5/2021Credit Suisse GroupBoost TargetNeutral$36.00 ➝ $40.00
2/5/2021Deutsche Bank AktiengesellschaftBoost TargetHold$32.00 ➝ $36.00
1/26/2021Morgan StanleyBoost TargetEqual Weight$31.00 ➝ $38.00
1/19/2021Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$40.00
11/20/2020Bank of AmericaUpgradeUnderperform ➝ Buy$30.00 ➝ $35.00
11/3/2020Credit Suisse GroupBoost TargetNeutral$31.00 ➝ $33.00
11/2/2020Morgan StanleyBoost TargetEqual Weight$30.00 ➝ $31.00
10/20/2020Morgan StanleyBoost TargetEqual Weight$28.00 ➝ $30.00
10/12/2020CitigroupUpgradeNeutral ➝ Buy$31.00
8/3/2020Morgan StanleyLower TargetEqual Weight$29.00 ➝ $28.00
7/31/2020Keefe, Bruyette & WoodsBoost TargetMarket Perform$30.00 ➝ $31.00
7/30/2020OppenheimerReiterated RatingBuy$39.00
7/14/2020Morgan StanleyBoost TargetEqual Weight$23.00 ➝ $29.00
7/13/2020OppenheimerBoost TargetOutperform$35.00 ➝ $39.00
7/10/2020Bank of AmericaBoost TargetUnderperform$25.00 ➝ $27.00
6/30/2020TD SecuritiesDowngradeHold$15.50 ➝ $17.00
6/17/2020OppenheimerInitiated CoverageBuy$35.00
6/8/2020CitigroupDowngradeBuy ➝ Neutral
6/8/2020CIBCUpgradeOutperformer$14.00 ➝ $17.00
5/15/2020Deutsche Bank AktiengesellschaftBoost TargetHold$23.00 ➝ $24.00
5/4/2020Morgan StanleyLower TargetEqual Weight$25.00 ➝ $23.00
5/1/2020CfraLower TargetHold$29.00 ➝ $25.00
5/1/2020Credit Suisse GroupLower TargetNeutral$25.00 ➝ $24.00
5/1/2020OppenheimerLower TargetOutperform$37.00 ➝ $31.00
4/17/2020Morgan StanleyLower TargetEqual Weight$27.00 ➝ $25.00
4/15/2020CitigroupUpgradeNeutral ➝ Buy$34.00
4/9/2020Deutsche Bank AktiengesellschaftLower TargetHold$27.00 ➝ $25.00
3/23/2020Bank of AmericaDowngradeNeutral ➝ Underperform$24.00 ➝ $17.00
3/18/2020Deutsche Bank AktiengesellschaftLower TargetHold$32.00 ➝ $27.00
3/13/2020Morgan StanleyLower TargetEqual Weight$32.00 ➝ $27.00
2/6/2020Deutsche Bank AktiengesellschaftBoost TargetHold$31.00 ➝ $32.00
2/6/2020JPMorgan Chase & Co.Boost TargetOverweight$32.00 ➝ $34.00
2/6/2020Credit Suisse GroupLower TargetNeutral$33.00 ➝ $32.00
2/6/2020CitigroupDowngradeBuy ➝ Neutral$36.00 ➝ $35.00
2/6/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$36.00 ➝ $35.00
1/28/2020UBS GroupBoost TargetNeutral$31.00 ➝ $34.00
12/19/2019Deutsche Bank AktiengesellschaftBoost TargetHold$30.00 ➝ $31.00
12/12/2019UBS GroupDowngradeBuy ➝ Neutral$32.00 ➝ $31.00
12/10/2019Sandler O'NeillInitiated CoverageBuy$35.00
12/4/2019Credit Suisse GroupBoost TargetNeutral$27.00 ➝ $28.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.90 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 24 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 5 very negative mentions
Mentions as of
4/25/2024
  • 29 very positive mentions
  • 23 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
5/25/2024
  • 20 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 34 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 29 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
8/23/2024
  • 26 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 24 very positive mentions
  • 13 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 29 very positive mentions
  • 26 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024

Current Sentiment

  • 29 very positive mentions
  • 26 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

The Carlyle Group logo
The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. The firm invests across four segments which include Corporate Private Equity, Real Assets, Global Market Strategies, and Solutions. The firm typically invests in industrial, agribusiness, ecological sector, fintech, airports, parking, Plastics, Rubber, diversified natural resources, minerals, farming, aerospace, defense, automotive, consumer, retail, industrial, infrastructure, energy, power, healthcare, software, software enabled services, semiconductors, communications infrastructure, financial technology, utilities, gaming, systems and related supply chain, electronic systems, systems, oil and gas, processing facilities, power generation assets, technology, systems, real estate, financial services, transportation, business services, telecommunications, media, and logistics sectors. Within the industrial sector, the firm invests in manufacturing, building products, packaging, chemicals, metals and mining, forestry and paper products, and industrial consumables and services. In consumer and retail sectors, it invests in food and beverage, retail, restaurants, consumer products, domestic consumption, consumer services, personal care products, direct marketing, and education. Within aerospace, defense, business services, and government services sectors, it seeks to invest in defense electronics, manufacturing and services, government contracting and services, information technology, distribution companies. In telecommunication and media sectors, it invests in cable TV, directories, publishing, entertainment and content delivery services, wireless infrastructure/services, fixed line networks, satellite services, broadband and Internet, and infrastructure. Within real estate, the firm invests in office, hotel, industrial, retail, for sale residential, student housing, hospitality, multifamily residential, homebuilding and building products, and senior living sectors. The firm seeks to make investments in growing business including those with overleveraged balance sheets. The firm seeks to hold its investments for four to six years. In the healthcare sector, it invests in healthcare services, outsourcing services, companies running clinical trials for pharmaceutical companies, managed care, pharmaceuticals, pharmaceutical related services, healthcare IT, medical, products, and devices. It seeks to invest in companies based in Sub-Saharan focusing on Ghana, Kenya, Mozambique, Botswana, Nigeria, Uganda, West Africa, North Africa and South Africa focusing on Tanzania and Zambia; Asia focusing on Pakistan, India, South East Asia, Indonesia, Philippines, Vietnam, Korea, and Japan; Australia; New Zealand; Europe focusing on France, Italy, Denmark, United Kingdom, Germany, Austria, Belgium, Finland, Iceland, Ireland, Netherlands, Norway, Portugal, Spain, Benelux , Sweden, Switzerland, Hungary, Poland, and Russia; Middle East focusing on Bahrain, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, Turkey, and UAE; North America focusing on United States which further invest in Southeastern United States, Texas, Boston, San Francisco Bay Area and Pacific Northwest; Asia Pacific; Soviet Union, Central-Eastern Europe, and Israel; Nordic region; and South America focusing on Mexico, Argentina, Brazil, Chile, and Peru. The firm seeks to invest in food, financial, and healthcare industries in Western China. In the real estate sector, the firm seeks to invest in various locations across Europe focusing on France and Central Europe, United States, Asia focusing on China, and Latin America. It typically invests between $1 million and $50 million for venture investments and between $50 million and $2 billion for buyouts in companies with enterprise value of between $31.57 million and $1000 million and sales value of $10 million and $500 million. It seeks to invest in companies with market capitalization greater than $50 million and EBITDA between $5 million to $25 million. It prefers to take a majority or a minority stake. While investing in Japan, it does not invest in companies with more than 1,000 employees and prefers companies' worth between $100 million and $150 million. The firm originates, structures, and acts as lead equity investor in the transactions. The Carlyle Group Inc. was founded in 1987 and is based in Washington, District of Columbia with additional offices in 21 countries across 5 continents (North America, South America, Asia, Australia and Europe).
Read More

Today's Range

Now: $51.23
Low: $50.02
High: $51.47

50 Day Range

MA: $47.75
Low: $38.77
High: $54.23

52 Week Range

Now: $51.23
Low: $31.79
High: $54.52

Volume

2,100,629 shs

Average Volume

2,346,897 shs

Market Capitalization

$18.32 billion

P/E Ratio

176.66

Dividend Yield

2.77%

Beta

1.7

Frequently Asked Questions

What sell-side analysts currently cover shares of The Carlyle Group?

The following Wall Street analysts have issued research reports on The Carlyle Group in the last year: Barclays PLC, Citigroup Inc., Deutsche Bank Aktiengesellschaft, Evercore ISI, Jefferies Financial Group Inc., JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer Holdings Inc., Redburn Atlantic, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for CG.

What is the current price target for The Carlyle Group?

0 Wall Street analysts have set twelve-month price targets for The Carlyle Group in the last year. Their average twelve-month price target is $53.33, suggesting a possible upside of 4.1%. Oppenheimer Holdings Inc. has the highest price target set, predicting CG will reach $85.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $44.00 for The Carlyle Group in the next year.
View the latest price targets for CG.

What is the current consensus analyst rating for The Carlyle Group?

The Carlyle Group currently has 9 hold ratings and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CG, but not buy more shares or sell existing shares.
View the latest ratings for CG.

What other companies compete with The Carlyle Group?

Other companies that are similar to The Carlyle Group include Morningstar, Franklin Resources, Invesco, Legg Mason and Eaton Vance. Learn More about companies similar to The Carlyle Group.

How do I contact The Carlyle Group's investor relations team?

The Carlyle Group's physical mailing address is 1001 Pennsylvania Avenue NW, Washington DC, 20004. The financial services provider's listed phone number is (202) 729-5626 and its investor relations email address is [email protected]. The official website for The Carlyle Group is www.carlyle.com. Learn More about contacing The Carlyle Group investor relations.